A Divesture To Kick Up Valuation For Genzyme Drives U.S. Expansion For Japanese Diagnostic Firm
This article was originally published in PharmAsia News
Executive Summary
TOKYO - True to its word, Genzyme sold off its diagnostics business, the second of three units the company said it would divest to generate shareholder value, but which is seen largely as a move to enhance valuation as it courts buyers. The Genzyme unit was sold to Japanese firm Sekisui Chemical, a young company that has been quick to expand its presence in the U.S
You may also be interested in...
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q4 2010
In the fourth quarter, medical device companies raised $1.1 billion, a third of which was represented by follow-on public offerings. Acquisitions were strong overall, holding steady with 15 transactions - the same as Q3 - but only slightly less in money paid, $6 billion. In vitro diagnostic/research companies, like medical device, also ended 2010 on a high note, with funding totaling $511 million in Q4. The majority of the money spent on IVD/research acquisitions came from Thermo Fisher Scientific's buy of Dionex for $2.1 billion.
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q4 2010
In the fourth quarter, medical device companies raised $1.1 billion, a third of which was represented by follow-on public offerings. Acquisitions were strong overall, holding steady with 15 transactions - the same as Q3 - but only slightly less in money paid, $6 billion. In vitro diagnostic/research companies, like medical device, also ended 2010 on a high note, with funding totaling $511 million in Q4. The majority of the money spent on IVD/research acquisitions came from Thermo Fisher Scientific's buy of Dionex for $2.1 billion.
Following Through On Prior Plan, Genzyme Sells Off Genetic Testing Unit
Sale of Genzyme Genetics for $925 million to LabCorp seen as enhancing the biotech's potential purchase value.
Need a specific report? 1000+ reports available
Buy Reports